ALKERMES | Revenu Net



Net Income Changement Date
AbbVie USD 938M 348M 2025-06
Acadia Pharmaceuticals USD 26.67M 7.68M 2025-06
ALKERMES USD 87.1M 64.63M 2025-06
Amgen USD 1.43B 298M 2025-06
Biogen USD 634.8M 394.3M 2025-06
BioMarin Pharmaceutical USD 240.53M 54.85M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Eli Lilly USD 5.66B 2.9B 2025-06
Gilead Sciences USD 1.96B 645M 2025-06
Ionis Pharmaceuticals USD 123.55M 270.49M 2025-06
J&J USD 5.54B 5.46B 2025-06
Malin Corporation EUR 0 0 2024-12
Merck USD 4.43B 652M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Otsuka Holdings JPY 88.53B 3.53B 2025-06
Pfizer USD 2.91B 58M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Vertex Pharmaceuticals USD 1.03B 386.6M 2025-06


ALKERMES Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.